Search research articles
Contact Us
Filters
Showing results (71-80 of 352) with videos related to
Page
of 36
Sort By:
Plos One
|
June 24, 2011
Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer
Jingyao Dai, Jian Gu, Charles Lu, et al.
Communications Biology
|
February 25, 2022
TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
Ismail M Meraz, Mourad Majidi, RuPing Shao, et al.
Cancer Research
|
January 25, 2005
Cell cycle checkpoints, DNA damage/repair, and lung cancer risk
Xifeng Wu, Jack A Roth, Hua Zhao, et al.
Plos One
|
October 23, 2013
The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner
Jieru Meng, Mourad Majidi, Bingliang Fang, et al.
Oncogene
|
April 18, 2002
Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells
Koh Katsuda, Masafumi Kataoka, Futoshi Uno, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing
Abujiang Pataer, Wenxian Hu, Lu Xiaolin, et al.
Cancer Research
|
August 18, 2004
Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells
Masahiko Nishizaki, Ji-Ichiro Sasaki, Bingliang Fang, et al.
Scientific Reports
|
May 28, 2016
Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S
Huakang Tu, John V Heymach, Chi-Pang Wen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 10, 2004
Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression
Isao Ito, Tomoyuki Saeki, Imran Mohuiddin, et al.
Chest
|
March 26, 2009
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data
William N William, Heather Y Lin, J Jack Lee, et al.
Page
of 36
Search research articles
Search
Showing results (71-80 of 352) with videos related to
Sort By:
Page
of 36
Plos One
|
June 24, 2011
Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer
Jingyao Dai, Jian Gu, Charles Lu, et al.
Communications Biology
|
February 25, 2022
TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
Ismail M Meraz, Mourad Majidi, RuPing Shao, et al.
Cancer Research
|
January 25, 2005
Cell cycle checkpoints, DNA damage/repair, and lung cancer risk
Xifeng Wu, Jack A Roth, Hua Zhao, et al.
Plos One
|
October 23, 2013
The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner
Jieru Meng, Mourad Majidi, Bingliang Fang, et al.
Oncogene
|
April 18, 2002
Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells
Koh Katsuda, Masafumi Kataoka, Futoshi Uno, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing
Abujiang Pataer, Wenxian Hu, Lu Xiaolin, et al.
Cancer Research
|
August 18, 2004
Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells
Masahiko Nishizaki, Ji-Ichiro Sasaki, Bingliang Fang, et al.
Scientific Reports
|
May 28, 2016
Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S
Huakang Tu, John V Heymach, Chi-Pang Wen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 10, 2004
Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression
Isao Ito, Tomoyuki Saeki, Imran Mohuiddin, et al.
Chest
|
March 26, 2009
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data
William N William, Heather Y Lin, J Jack Lee, et al.
Page
of 36